Biolase EPS - Earnings per Share 2010-2023 | BIOL
Biolase eps - earnings per share from 2010 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| Biolase Annual EPS |
| 2023 |
$-29.44 |
| 2022 |
$-418.13 |
| 2021 |
$-283.12 |
| 2020 |
$-1,399.00 |
| 2019 |
$-1,925.00 |
| 2018 |
$-2,625.00 |
| 2017 |
$-3,525.00 |
| 2016 |
$-3,625.00 |
| 2015 |
$-4,375.00 |
| 2014 |
$-5,625.00 |
| 2013 |
$-4,375.00 |
| 2012 |
$-1,250.00 |
| 2011 |
$-1,875.00 |
| 2010 |
$-5,636.42 |
| 2009 |
$-1,434.16 |
| Biolase Quarterly EPS |
| 2023-12-31 |
$1.38 |
| 2023-09-30 |
$-3.89 |
| 2023-06-30 |
$-8.93 |
| 2023-03-31 |
$-18.00 |
| 2022-12-31 |
$-134.79 |
| 2022-09-30 |
$-110.36 |
| 2022-06-30 |
$-91.98 |
| 2022-03-31 |
$-81.00 |
| 2021-12-31 |
$-79.12 |
| 2021-09-30 |
$-54.00 |
| 2021-06-30 |
$-12.00 |
| 2021-03-31 |
$-138.00 |
| 2020-12-31 |
$-99.00 |
| 2020-09-30 |
$-525.00 |
| 2020-06-30 |
$-300.00 |
| 2020-03-31 |
$-475.00 |
| 2019-12-31 |
$-275.00 |
| 2019-09-30 |
$-625.00 |
| 2019-06-30 |
$-450.00 |
| 2019-03-31 |
$-575.00 |
| 2018-12-31 |
$-825.00 |
| 2018-09-30 |
$-575.00 |
| 2018-06-30 |
$-600.00 |
| 2018-03-31 |
$-625.00 |
| 2017-12-31 |
$-500.00 |
| 2017-09-30 |
$-750.00 |
| 2017-06-30 |
$-1,525.00 |
| 2017-03-31 |
$-750.00 |
| 2016-12-31 |
$-875.00 |
| 2016-09-30 |
$-1,125.00 |
| 2016-06-30 |
$-750.00 |
| 2016-03-31 |
$-875.00 |
| 2015-12-31 |
$-625.00 |
| 2015-09-30 |
$-1,125.00 |
| 2015-06-30 |
$-1,500.00 |
| 2015-03-31 |
$-1,125.00 |
| 2014-12-31 |
$-875.00 |
| 2014-09-30 |
$-1,000.00 |
| 2014-06-30 |
$-2,125.00 |
| 2014-03-31 |
$-1,625.00 |
| 2013-12-31 |
$-875.00 |
| 2013-09-30 |
$-1,500.00 |
| 2013-06-30 |
$-1,000.00 |
| 2013-03-31 |
$-1,000.00 |
| 2012-12-31 |
$349.04 |
| 2012-09-30 |
$-247.52 |
| 2012-06-30 |
$-738.86 |
| 2012-03-31 |
$-612.66 |
| 2011-12-31 |
$-788.59 |
| 2011-09-30 |
$-363.94 |
| 2011-06-30 |
$-362.13 |
| 2011-03-31 |
$-360.33 |
| 2010-12-31 |
$90.53 |
| 2010-09-30 |
$-1,183.30 |
| 2010-06-30 |
$-1,991.69 |
| 2010-03-31 |
$-2,551.96 |
| 2009-12-31 |
$-859.91 |
| 2009-09-30 |
$459.40 |
| 2009-06-30 |
$1,148.50 |
| 2009-03-31 |
$-2,182.15 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$0.005B |
$0.049B |
|
Biolaw Technology, Inc. is the world's leading dental laser company, is a medical technology company that develops, manufactures and markets lasers and related products focused on technologies that advance the practice of dentistry and medicine. The Company's products incorporate patented and patent pending technologies designed to provide clinically superior performance with less pain and faster recovery times. BIOLASE's principal products are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications. Other products under development address ophthalmology and other medical and consumer markets.
|
